well Koo I have to agree with you when it comes to an investor having determined for himself that management is bad; however I do not believe that that is the case here.

I see the management as being accepted by our major shareholders who range from the large corporate shareholder who put a great deal of money in to the billionaire shareholder and other large shareholders. When I see a billionaire investor relatively happy with a situation I tend to be relatively happy with it as well.

Given their (major shareholders) acceptance of the performance of management I cannot find myself saying anything particularly bad about the current management. I quibble with the fact that management salaries seem excessive to me; but that is a quibble.

I am considering the fact that I believe the payoff to we who are longterm shareholders at least in the aggregate is being optimized, in my opinion, by not having sold out to big pharma at what i believe would have been too low a price in prior years compared to what I believe it was worth, and which I believe we will get from holding on till we see the success in recognition of the value of Apabetalone after phase three success.

I also agree that getting money into my hand where it can be invested wisely in wine women and song is desireable; but I believe the investment in RVX and Zenith will pay off handsomely in dividends and partially in Capital gain if I decide to sell a portion of my shares re wine women and song rather than leave it all to my children and grandchildren.